NIU’s Global Round-up: DSM’s nutrition boss talks personalized nutrition, Argentina’s proposed regulatory changes, and AI-powered peptides to fight muscle atrophy

By Stephen Daniells contact

- Last updated on GMT

© Getty Images / bluebay2014
© Getty Images / bluebay2014
It’s a global industry and there’s a lot happening. We know it’s not always easy keeping up with everything that’s happening around the world that could impact the US dietary supplements industry. The answer? Our weekly round-up of key news from across the globe.


Argentina assessing comments after public consultation on dietary supplements regs

Argentina’s National Administration of Drugs, Foods and Medical Devices (ANMAT) is considering changes to the regulations for dietary supplements, including changing maximum levels for vitamins and minerals, and cutting the list of permitted botanicals.

The public comment period on the proposed changes recently closed, and ANMAT is now working through those submissions.

Among the proposed changes are a revision of maximum limits for vitamins and minerals, and increasing the minimum levels for vitamins and minerals from 20 to 30% of the RDI per unit (one tablet, one capsule, one tablespoon or other).

The vitamin and mineral content in dietary supplements also may not exceed the levels of No Observation of Adverse Effects (NOEA), stated the consultation document.

According to the proposed regulatory updates, the permitted botanical list could be cut from 35 to 27 species.

For more on this, please visit NutraIngredients-LATAM​.


Nuritas explores nutritional means to fight muscle atrophy in AI-powered peptide pact

Ireland-based AI company Nuritas is partnering with Maastricht University in the Netherlands to discover nutritional interventions that can help preserve muscle mass and strength in later life.

The collaboration will reportedly harness a natural peptide network that may redress imbalances in muscle metabolism as it enters the clinical trial phase.

The peptide network is the result of an integrative Artificial Intelligence (AI) approach, which also includes in-silico predictions validated by Nuritas’ in-house laboratory and team of scientists.

The same technology was responsible for the discovery of bioactive peptides such as PeptAIde​, an ingredient that was the culmination of a partnership between Nuritas and BASF formed back in January 2017. Nuritas has also announced partnerships with other heavyweights, such as food giants Nestlé and dietary supplements giant Pharmavite.

For more on this, please click HERE​.

Europe/ Asia

DSM nutrition boss on why personalized nutrition ‘is the future’ for dietary supplements

In an exclusive interview with NutraIngredients-Asia​, DSM’s Nutritional Product’s President and CEO Chris Goppelsroeder said that, while personalized nutrition is the future, a number of shortcomings have to be overcome first.

DNA data © Getty Images Rost-9D
© Getty Images / Rost-9D

Goppelsroeder added that, at present, he didn’t believe anyone had yet found the optimal solution or product offering for personalized nutrition to fulfil its full consumer and public health potential.

“Today, there are a number of problems in that whole feedback loop, from the invasive taking of blood, to the long lead time for results, and what comes back from the lab sometimes looks like you need a PhD to understand it,”​ he said.

“The true realization of personalized nutrition is not yet out there, in terms of the right measurement, the right products and the right feedback that is useful for many people.

“We need to replace the 10 supplements you may take in the morning to something that is more targeted to the individual, has a better consumer feel to it and is linked to continual feedback – that is the new world.”

Goppelsroeder referenced a “Nespresso-style” capsule product that could offer a morning drink containing an individuals’ nutritional requirements.

“I could see that working well in the US, where the demand is consumer –driven, but perhaps less so in some other markets,” ​he added.

Related news

Show more

Follow us


View more